10 March 2023
Deals | France | Banking & Finance
Gide has advised the European Investment Bank (EIB) on the signature of a venture debt granted to GeNeuro Innovation SAS, the French research and development subsidiary of GeNeuro, a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe consequences of COVID-19 (PASC, post-COVID or long COVID), for a total amount of up to €25 million, supported by the InvestEU programme. The credit agreement is supplemented by a Swiss law warrant agreement between GeNeuro SA and the EIB.
The Gide team was led by partner Farah El-Bsat, working with associate Eric Bolis.
Pestalozzi Law Firm acted as Swiss legal adviser.